首页> 美国卫生研究院文献>Kidney International Reports >Soluble Urokinase-type Plasminogen Activator Receptor (suPAR) and Impaired Kidney Function in the Population-based Malmö Diet and Cancer Study

【2h】

Soluble Urokinase-type Plasminogen Activator Receptor (suPAR) and Impaired Kidney Function in the Population-based Malmö Diet and Cancer Study

机译：基于人群的马尔默饮食和癌症研究中的可溶性尿激酶型纤溶酶原激活剂受体（suPAR）和肾功能受损

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

IntroductionThe soluble urokinase-type plasminogen activator receptor (suPAR) has recently been associated with a decline in kidney function and incidence of chronic kidney disease in patients with cardiovascular disease undergoing cardiac catheterization, yet little is known whether suPAR is associated with deterioration of kidney function in the general population.

机译：前言可溶性尿激酶型纤溶酶原激活剂受体（suPAR）最近与患有心脏导管插入术的心血管疾病患者的肾功能下降和慢性肾脏疾病的发生率相关，但鲜为人知的是suPAR是否与肾功能恶化有关。普通人群。

著录项

期刊名称 Kidney International Reports
作者
Christina-Alexandra Schulz; Margaretha Persson; Anders Christensson; George Hindy; Peter Almgren; Peter M. Nilsson; Olle Melander; Gunnar Engström; Marju Orho-Melander;
展开▼
作者单位

展开▼
年(卷),期 2017(2),2
年度 2017
页码 239–247
总页数 9
原文格式 PDF
正文语种
中图分类泌尿科学（泌尿生殖系疾病）;小儿泌尿科学;肾疾病;
关键词
chronic kidney disease renal function suPAR;

机译：慢性肾脏疾病;肾功能;suPAR;

相似文献

外文文献
中文文献
专利

1. Soluble Urokinase-type Plasminogen Activator Receptor (suPAR) and Impaired Kidney Function in the Population-based Malm? Diet and Cancer Study [J] . Christina-Alexandra Schulz, Margaretha Persson, Anders Christensson, Kidney International Reports . 2017,第2期

机译：可溶性尿激酶型纤溶酶原激活物受体（suPAR）和基于人群的马尔姆肾功能受损？饮食与癌症研究
2. Soluble urokinase plasminogen activator receptor in plasma is associated with incidence of CVD. Results from the Malm? Diet and Cancer Study [J] . PerssonM., Engstr?mG., Bj?rkbackaH., Atherosclerosis . 2012,第2期

机译：血浆中可溶性尿激酶纤溶酶原激活物受体与CVD的发生有关。来自马尔姆的结果？饮食与癌症研究
3. Cell Cycle Biomarkers and Soluble Urokinase-Type Plasminogen Activator Receptor for the Prediction of Sepsis-Induced Acute Kidney Injury Requiring Renal Replacement Therapy: A Prospective, Exploratory Study [J] . Nusshag Christian, Rupp Christoph, Schmitt Felix, Critical care medicine . 2019,第12期

机译：细胞周期生物标志物和可溶性尿激酶型纤溶酶原激活因子，用于预测败血症诱导的急性肾损伤，需要肾置换疗法：一项潜在的探索性研究
4. Inhibition of the Tumor-Associated Urokinase-Type Plasminogen Activation System: Effects of High-Level Synthesis of Soluble Urokinase Receptor in Ovarian and Breast Cancer Cells In Vitro and In Vivo [C] . Viktor Magdolen International Meeting on Molecular Staging on Cancer . 2003

机译：抑制肿瘤相关的尿激酶型纤溶酶原激活系统：高水平合成在体外和体内卵巢癌细胞中可溶性尿激酶受体的影响
5. Estrogen receptor beta: Influence on urokinase-type plasminogen activator in vascular smooth muscle cells. [D] . Paradis, Madeleine Aimee. 2003

机译：雌激素受体β：对血管平滑肌细胞中尿激酶型纤溶酶原激活剂的影响。
6. Increased Serum Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) Levels in FSGS: A Meta-Analysis [O] . Jiwon M. Lee, Jae Won Yang, Andreas Kronbichler, 2019

机译：FSGS中血清可溶性尿激酶型纤溶酶原激活物受体（suPAR）水平升高：一项荟萃分析
7. Soluble Urokinase-type Plasminogen Activator Receptor (suPAR) and Impaired Kidney Function in the Population-based Malmö Diet and Cancer Study [O] . Christina-Alexandra Schulz, Margaretha Persson, Anders Christensson, 2017

机译：基于人群的malmö饮食和癌症研究中可溶性尿激酶型纤溶酶原激活物受体（supaR）和肾功能受损

Soluble Urokinase-type Plasminogen Activator Receptor (suPAR) and Impaired Kidney Function in the Population-based Malmö Diet and Cancer Study

摘要

著录项

相似文献

相关主题

期刊订阅